TY - JOUR T1 - Ethnic disparities in hospitalisation and hospital-outcomes during the second wave of COVID-19 infection in east London JF - medRxiv DO - 10.1101/2021.07.05.21260026 SP - 2021.07.05.21260026 AU - Y I Wan AU - V J Apea AU - R Dhairyawan AU - Z A Puthucheary AU - R M Pearse AU - C M Orkin AU - J R Prowle Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/07/2021.07.05.21260026.abstract N2 - Objectives To determine if changes in public behaviours, developments in COVID-19 treatments, improved patient care, and directed policy initiatives have altered outcomes for minority ethnic groups in the second pandemic wave.Design Prospectively defined observational study using registry data.Setting Four acute NHS Hospitals in east London.Participants Patients aged ≥16 years with an emergency hospital admission with SARS-CoV-2 infection between 1st September 2020 and 17th February 2021.Main outcome measures Primary outcome was 30-day mortality from time of index COVID-19 hospital admission. Secondary endpoints were 90-day mortality and need for ICU admission. Multivariable survival analysis was used to assess associations between ethnicity and mortality accounting for predefined risk factors. Age-standardised rates of hospital admission relative to the local population were compared between ethnic groups.Results Of 5533 patients, the ethnic distribution was White (n=1805, 32.6%), Asian/Asian British (n=1983, 35.8%), Black/Black British (n=634, 11.4%), Mixed/Other (n=433, 7.8%), and unknown (n=678, 12.2%). Excluding 678 patients with missing data, 4855 were included in multivariable analysis. Relative to the White population, Asian and Black populations experienced 4.1 times (3.77-4.39) and 2.1 times (1.88-2.33) higher rates of age-standardised hospital admission. After adjustment for various patient risk factors including age, sex, and socioeconomic deprivation, Asian patients were at significantly higher risk of death within 30 days (HR 1.47 [1.24-1.73]). No association with increased risk of death in hospitalised patients was observed for Black or Mixed/Other ethnicity.Conclusions Asian and Black ethnic groups continue to experience poor outcomes following COVID-19. Despite higher-than-expected rates of admission, Black and Asian patients experienced similar or greater risk of death in hospital, implying a higher overall risk of COVID-19 associated death in these communities.Strengths and limitations of this studyThis study represents one of the largest descriptors of outcomes in minority ethnic patients with COVID-19 distinguished by the majority ethnically diverse cohort within a catchment area of approximately one million people in the east of London.Large absolute numbers of patients drawn from a single geographic region and treated within the same hospital system minimize many of the geographic biases present within other studies including the impact of variation in transmission risk.Our analyses are strengthened by adherence to a prespecified analysis plan, inclusion of a detailed baseline, comorbidity, and COVID-19 risk factors in multivariable modelling, and sensitivity tests using different measures of comorbidity.However as with all observational studies, not all potential contributing risk factors could be assessed, including other measures of baseline health status such as nutritional or lifestyle influences as well as contextual factors such as household composition and occupation.We were not able to include suspected but not proven COVID-19 cases or community cases not requiring hospital admission or the effect of the differing viral strains in the first and second wave.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by NHS England Health Research Authority and Yorkshire & The Humber - Bradford Leeds Research Ethics Committee and approved as anonymised analysis of routinely collected patient data without need for direct consent (Ethics reference 20/YH/0159).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe statistical analysis plan can be accessed online. The authors will be happy to consider additional analyses of the anonymised dataset on request. The need for stringent measures to prevent re-identification of individuals within a discrete geographical location and limited time-period however preclude sharing of patient level dataset in a GDPR compliant form. ER -